ロード中...

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

詳細記述

保存先:
書誌詳細
出版年:J Hepatocell Carcinoma
主要な著者: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
フォーマット: Artigo
言語:Inglês
出版事項: Dove 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://ncbi.nlm.nih.gov/pubmed/33824863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!